Jian Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jian Li has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Li Zhou
Department of Oncology Children's Hospital of Nanjing Medical University Nanjing China
8 shared publicationsLulu He
Department of Hematology, Children’s Hospital of Nanjing Medical University, Nanjing, China
6 shared publicationsTao Li
Department of Oncology Children's Hospital of Nanjing Medical University Nanjing China
6 shared publications- Yongjun Fang
Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing, China.
6 shared publications Jun Wang
Children’s Hospital of Nanjing Medical University
5 shared publicationsJianfeng Zhou
Department of Oncology Children's Hospital of Nanjing Medical University Nanjing China
4 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Elsevier in Cancer Genetics
- Vol. 308-309, 295-303
Clinical and molecular features of NUTM1-rearranged B-ALL in two infants and two children: a four-case series
- 14 November 2026
- Published by Elsevier in Cancer Genetics
- Vol. 308-309, 295-303
Open AccessClinical and molecular features of NUTM1-rearranged B-ALL in two infants and two children: a four-case series
- Open Access
- 26 August 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Clinical characteristics and prognostic factors in pediatric atypical teratoid/rhabdoid tumor: a single-center retrospective study
- 26 August 2026
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessClinical characteristics and prognostic factors in pediatric atypical teratoid/rhabdoid tumor: a single-center retrospective study
- 23 September 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (12) , e32079
Sintilimab Bevacizumab as Salvage Therapy in Pediatric Thymic Lymphoepithelioma‐Like Carcinoma
- 23 September 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (12) , e32079
Sintilimab Bevacizumab as Salvage Therapy in Pediatric Thymic Lymphoepithelioma‐Like Carcinoma
- 14 September 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (12) , e32066
Successful Salvage Treatment With Afatinib and Anti‐PD‐1 Combined Chemotherapy in a Pediatric Patient With Relapsed Cellular‐Type Congenital Mesoblastic Nephroma Harboring an EGFR‐KDD Mutation
- 14 September 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (12) , e32066
Successful Salvage Treatment With Afatinib and Anti‐PD‐1 Combined Chemotherapy in a Pediatric Patient With Relapsed Cellular‐Type Congenital Mesoblastic Nephroma Harboring an EGFR‐KDD Mutation
- 18 April 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (7) , e31737
A Rare Case of Recurrent Infant Mediastinal Malignant Rhabdoid Tumor With MSH2 Germline Mutation
- 18 April 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (7) , e31737
A Rare Case of Recurrent Infant Mediastinal Malignant Rhabdoid Tumor With MSH2 Germline Mutation
- 31 January 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (4) , e31569
Clinical and Genetic Characteristics of Pediatric Colorectal Cancer
Background: Compared to colorectal cancer (CRC) in adults, CRC in children is extremely rare. Although its incidence has increased recently, there is a lack of clinical research on the disease. Inherited cancer susceptibility syndromes (ICSS), a group of disorders in which patients are predisposed to susceptibility to a wide range of tumors as a result of pathogenic mutations in genes in their germ line, are an important cause of CRC in children. Delayed diagnosis due to atypical clinical presentation, as well as limited awareness of ICSS among doctors, contributes to poor outcomes in juvenile CRC patients. Therefore, improving clinicians’ understanding of the diagnosis and treatment of the disease is crucial to enhancing children's prognosis with CRC.Methods: Clinical data and laboratory reports were collected from eight pediatric patients diagnosed with CRC at the Children's Hospital of Nanjing Medical University between 2020 and 2023. The clinical and genetic characteristics of these patients were evaluated and compared with other patients with early‐onset CRC in the literature.Results: A total of 8 children with CRC were enrolled in the study, including 5 male and 3 female children, with a median age of 140 (73–177) months. The main clinical manifestations were unexplained abdominal pain, abdominal distension, vomiting, and hematochezia. Three cases of intestinal obstruction and two cases of intestinal intussusception occurred among the patients. All eight children underwent surgical treatment, including one case of snare resection of rectal polyp, five cases of subtotal colectomy, and two cases of radical resection of CRC. One case of radical resection of CRC utilized laparoscopic and colonoscopic combined resection guided by indocyanine green (ICG) fluorescence navigation system. Postoperative combination of pathological pictures and immunohistochemical (IHC) staining results confirmed high‐grade squamous intraepithelial lesion (HSIL) in Case 1, and mucinous adenocarcinoma in the remaining seven cases. Out of eight pediatric patients with CRC, except for Case 1 and Case 7, who did not undergo chemotherapy, the remaining six patients all received postoperative chemotherapy; among them, the patients in Cases 1, 6, 7, and 8 achieved complete remission, whereas the patients in Cases 2 and 4 died due to postoperative recurrence and distant metastasis, the patient in Case 3 is still undergoing chemotherapy, and the patient in Case 5 was lost to follow‐up after surgery. The results of the genetic test report showed that two children had ICSS caused by mismatch gene repair system defects (deficient MMR, dMMR); in Case 3, the child's genetic test results showed heterozygous mutation of MSH2 in the MMR gene, with high microsatellite instability (MSI‐H), and the results of the methylation test of the MLH1 gene were negative, which, combined with the family history of heterozygous mutation of the MSH2 gene, ruled out sporadic CRC and led to the diagnosis of Lynch syndrome (LS); Case 8 genetic testing showed two heterozygous mutations in the MMR gene PMS2 with microsatellite stabilization (MSS), and a diagnosis of constitutional mismatch repair deficiency (CMMRD) was considered.Conclusion: Pediatric CRC is confronted with delayed diagnosis and poor clinical prognosis, mainly due to nonspecific clinical presentation and the low index of suspicion among clinicians. Early detection and diagnosis is the fundamental guarantee to improve the prognosis of pediatric CRC patients, and pediatric surgeons enhance the understanding of pediatric CRC and standardize the surgery as much as possible.
- 31 January 2025
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 72 (4) , e31569
Clinical and Genetic Characteristics of Pediatric Colorectal Cancer
Background: Compared to colorectal cancer (CRC) in adults, CRC in children is extremely rare. Although its incidence has increased recently, there is a lack of clinical research on the disease. Inherited cancer susceptibility syndromes (ICSS), a group of disorders in which patients are predisposed to susceptibility to a wide range of tumors as a result of pathogenic mutations in genes in their germ line, are an important cause of CRC in children. Delayed diagnosis due to atypical clinical presentation, as well as limited awareness of ICSS among doctors, contributes to poor outcomes in juvenile CRC patients. Therefore, improving clinicians’ understanding of the diagnosis and treatment of the disease is crucial to enhancing children's prognosis with CRC.Methods: Clinical data and laboratory reports were collected from eight pediatric patients diagnosed with CRC at the Children's Hospital of Nanjing Medical University between 2020 and 2023. The clinical and genetic characteristics of these patients were evaluated and compared with other patients with early‐onset CRC in the literature.Results: A total of 8 children with CRC were enrolled in the study, including 5 male and 3 female children, with a median age of 140 (73–177) months. The main clinical manifestations were unexplained abdominal pain, abdominal distension, vomiting, and hematochezia. Three cases of intestinal obstruction and two cases of intestinal intussusception occurred among the patients. All eight children underwent surgical treatment, including one case of snare resection of rectal polyp, five cases of subtotal colectomy, and two cases of radical resection of CRC. One case of radical resection of CRC utilized laparoscopic and colonoscopic combined resection guided by indocyanine green (ICG) fluorescence navigation system. Postoperative combination of pathological pictures and immunohistochemical (IHC) staining results confirmed high‐grade squamous intraepithelial lesion (HSIL) in Case 1, and mucinous adenocarcinoma in the remaining seven cases. Out of eight pediatric patients with CRC, except for Case 1 and Case 7, who did not undergo chemotherapy, the remaining six patients all received postoperative chemotherapy; among them, the patients in Cases 1, 6, 7, and 8 achieved complete remission, whereas the patients in Cases 2 and 4 died due to postoperative recurrence and distant metastasis, the patient in Case 3 is still undergoing chemotherapy, and the patient in Case 5 was lost to follow‐up after surgery. The results of the genetic test report showed that two children had ICSS caused by mismatch gene repair system defects (deficient MMR, dMMR); in Case 3, the child's genetic test results showed heterozygous mutation of MSH2 in the MMR gene, with high microsatellite instability (MSI‐H), and the results of the methylation test of the MLH1 gene were negative, which, combined with the family history of heterozygous mutation of the MSH2 gene, ruled out sporadic CRC and led to the diagnosis of Lynch syndrome (LS); Case 8 genetic testing showed two heterozygous mutations in the MMR gene PMS2 with microsatellite stabilization (MSS), and a diagnosis of constitutional mismatch repair deficiency (CMMRD) was considered.Conclusion: Pediatric CRC is confronted with delayed diagnosis and poor clinical prognosis, mainly due to nonspecific clinical presentation and the low index of suspicion among clinicians. Early detection and diagnosis is the fundamental guarantee to improve the prognosis of pediatric CRC patients, and pediatric surgeons enhance the understanding of pediatric CRC and standardize the surgery as much as possible.
- Open Access
- 29 August 2024
- Published by Wiley
Innovative treatment model for malignant rhabdoid tumor
MRT is a highly malignant tumor that commonly occurs in children. Despite the current multidisciplinary treatment approach combining surgery, chemotherapy, and radiotherapy, the 3-year survival rate for affected children remains significantly low. This article presents three cases where a novel chemotherapy regimen and maintenance therapy were employed in conjunction with surgical and radiation treatments, resulting in favorable therapeutic outcomes. These findings demonstrate the feasibility and potential of the innovative personalized treatment approach utilized. Personalized treatment involves tailoring therapeutic strategies to the specific characteristics and biological behavior of individual patients. This approach holds promise in improving outcomes for children with MRT. Further research and clinical application will contribute to advancing the use of personalized treatment in the management of MRT.
- 29 August 2024
- Published by Wiley
Open AccessInnovative treatment model for malignant rhabdoid tumor
MRT is a highly malignant tumor that commonly occurs in children. Despite the current multidisciplinary treatment approach combining surgery, chemotherapy, and radiotherapy, the 3-year survival rate for affected children remains significantly low. This article presents three cases where a novel chemotherapy regimen and maintenance therapy were employed in conjunction with surgical and radiation treatments, resulting in favorable therapeutic outcomes. These findings demonstrate the feasibility and potential of the innovative personalized treatment approach utilized. Personalized treatment involves tailoring therapeutic strategies to the specific characteristics and biological behavior of individual patients. This approach holds promise in improving outcomes for children with MRT. Further research and clinical application will contribute to advancing the use of personalized treatment in the management of MRT.
- 12 November 2023
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (2) , e30765
Successful treatment of primary mediastinal choriocarcinoma with lung metastasis in a 13‐year‐old male
- 12 November 2023
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (2) , e30765
Successful treatment of primary mediastinal choriocarcinoma with lung metastasis in a 13‐year‐old male
- 25 July 2023
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (10) , 2955-2957
Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation
- 25 July 2023
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (10) , 2955-2957
Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation
- Open Access
- 30 January 2023
- Published by Springer Nature in Research Square
Posterior cerebral artery infarction associated with Mycoplasma pneumoniae infection in children
Acute ischemic stroke is a rare neurological complication of mycoplasma (MP) infection in children. We present two children with a MP respiratory infection who experienced posterior cerebral circulation stroke, which is particularly rare, and review the relevant literature. Both cases were pre-school children who initially acquired a respiratory illness then developed neurological signs including coma and seizure. Chest radiography revealed pneumonic infiltration with pleural effusion or pleural response. Anti-MP IgM antibody was positive. MP DNA was detected in the sputum using polymerase chain reaction analysis. Cerebrospinal fluid biochemical and pathological testing and MP DNA analysis were negative. D-dimer concentration was elevated. Neuroimaging showed posterior circulation occlusion and infarction. Clinical symptoms improved after treatment with erythromycin, anticoagulation, and thrombolysis; however, neurological sequelae remained and follow-up imaging revealed permanent effects. In our literature review, we identified 25 patients (including the two presented here) who developed an ischemic stroke as a complication of MP infection, 14 males and 11 females. Median age was six years (range, zero to 13) and average time between respiratory symptoms and stroke onset was 9 days. Nineteen strokes (76%) involved the anterior cerebral circulation; middle cerebral artery stroke was most prevalent (68%). Hemiparesis and seizure were the most common neurologic signs. Evidence of MP infection was found in the cerebrospinal fluid of five children. Coagulopathy affected nearly half. The most common treatments were macrolide antibiotics, immunoglobulin, glucocorticoid, and aspirin. Three patients (11%) died during follow-up, all from early respiratory deterioration. Thirteen children had varying degrees of permanent neurological sequelae. Cerebral infarction is a rare complication of MP infection in children and has a poor prognosis. Early identification of stroke risk factors and early intervention may improve outcomes.
- 30 January 2023
- Published by Springer Nature in Research Square
Open AccessPosterior cerebral artery infarction associated with Mycoplasma pneumoniae infection in children
Acute ischemic stroke is a rare neurological complication of mycoplasma (MP) infection in children. We present two children with a MP respiratory infection who experienced posterior cerebral circulation stroke, which is particularly rare, and review the relevant literature. Both cases were pre-school children who initially acquired a respiratory illness then developed neurological signs including coma and seizure. Chest radiography revealed pneumonic infiltration with pleural effusion or pleural response. Anti-MP IgM antibody was positive. MP DNA was detected in the sputum using polymerase chain reaction analysis. Cerebrospinal fluid biochemical and pathological testing and MP DNA analysis were negative. D-dimer concentration was elevated. Neuroimaging showed posterior circulation occlusion and infarction. Clinical symptoms improved after treatment with erythromycin, anticoagulation, and thrombolysis; however, neurological sequelae remained and follow-up imaging revealed permanent effects. In our literature review, we identified 25 patients (including the two presented here) who developed an ischemic stroke as a complication of MP infection, 14 males and 11 females. Median age was six years (range, zero to 13) and average time between respiratory symptoms and stroke onset was 9 days. Nineteen strokes (76%) involved the anterior cerebral circulation; middle cerebral artery stroke was most prevalent (68%). Hemiparesis and seizure were the most common neurologic signs. Evidence of MP infection was found in the cerebrospinal fluid of five children. Coagulopathy affected nearly half. The most common treatments were macrolide antibiotics, immunoglobulin, glucocorticoid, and aspirin. Three patients (11%) died during follow-up, all from early respiratory deterioration. Thirteen children had varying degrees of permanent neurological sequelae. Cerebral infarction is a rare complication of MP infection in children and has a poor prognosis. Early identification of stroke risk factors and early intervention may improve outcomes.